Press Release / Health and Fitness / Clinical Trial Supplies Market by Therapeutic, Products & Services - 2020

Clinical Trial Supplies Market by Therapeutic, Products & Services - 2020

Clinical Trial Supplies Market, by Products & Services (Logistics & Distribution, Manufacturing, Packaging & Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorder, Cardiovascular, Oncology) - Global Forecast to 2020
The global clinical trial supplies market is expected to reach USD 1,274.3 million by 2020 from USD 904.3 million in 2015, at a CAGR of 7.1%. The global clinical trial supplies market is broadly classified into manufacturing services, packaging and labeling services, and logistics and distribution services. The logistics and distribution segment is expected to account for the largest share of the global clinical trial supplies products market in 2015.
https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html
On the basis of phases, the clinical trial supplies market is segmented into phase I, phase II, and phase III. The phase III segment is expected to account for the largest share of the global clinical trial supplies market in 2015. On the basis of therapeutic areas, the clinical trial supplies market has been segmented into oncology, cardiovascular and metabolic disorders, respiratory diseases, CNS and mental disorders, dermatology disorders, blood disorders, infectious diseases, and others. The oncology segment is expected to account for the largest share of the global clinical trial supplies market in 2015.
Geographically, the clinical trial supplies market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising prevalence of patients suffering from chronic diseases, growing number of clinical trials, and the increasing number of life science research activities in the U.S. and Canada.
The major players in the clinical trial supplies market are Alamc Group LTD (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), Biocair (U.K.), and Thermo Fisher Scientific, Inc. (U.S.).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=172240059

Target Audience for this Report:

 Clinical trial supplies CROs
 Healthcare Institutions (Hospitals and Clinics)
 Clinical Trial Supplies Service Providers
 Research Institutions
 Research and Consulting Firms
 Environment, Health, and Safety Organizations

Value Addition for the Buyer:
This report aims to provide insights into the global clinical trial supplies market. It provides valuable information on the products and services, phases, and therapeutic areas in the clinical trial supplies market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product/service offerings and understand the strategies undertaken by them to be competitive in this market.
The above-mentioned information would benefit the buyer by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize the growth opportunities.
Customization Options:
• Company Information: Detailed company profiles of five or more market players
• Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market
• About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com